PYC THERAPEUTICS LIMITED - Announcements

0.42%

$1.19

Market Cap $691.1M

Healthcare Biotechnology

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

BPH Energy (ASX:BPH) heads to Federal Court to fight PEP-11 decision.

Announcements

Filter Results

All Price Sensitive Only

PYC	Sept 2019 Quarterly Shareholder Update and Appendix 4C	PRICE SENSITIVE	30/10/19	192.66KB	Share
PYC	Coprporate Governance Statement		21/10/19	128.14KB	Share
PYC	Appendix 4G		18/10/19	168.97KB	Share
PYC	Annual Report to shareholders		18/10/19	2.87MB	Share
PYC	Notice of Annual General Meeting/Proxy Form		18/10/19	260.4KB	Share
PYC	Investor Relations Presentation - October 2019		15/10/19	1.19MB	Share
PYC	Presentation Oligonucleotide Therapeutics Society Meeting		14/10/19	115.98KB	Share
PYC	Successful Major Milestone - Human Retina in a Dish Models	PRICE SENSITIVE	09/10/19	368.07KB	Share
PYC	Strategic Partnership and Lead Program	PRICE SENSITIVE	01/10/19	204.29KB	Share
PYC	Trading Halt	PRICE SENSITIVE	30/09/19	151.93KB	Share
PYC	Successful Time-Course Studies in Animals	PRICE SENSITIVE	25/09/19	85.62KB	Share
PYC	Full Year Statutory Accounts		17/09/19	862.71KB	Share
PYC	Scientific Advisory Board Appointment		13/09/19	157.06KB	Share
PYC	Investor Relations Presentation		04/09/19	1.44MB	Share
PYC	Successful Competitive Drug Evaluation in Animals	PRICE SENSITIVE	03/09/19	326.49KB	Share
PYC	Preliminary Final Report	PRICE SENSITIVE	30/08/19	300.77KB	Share
PYC	Investor Call		23/08/19	94.49KB	Share
PYC	Successful Time - Course Studies in Animals	PRICE SENSITIVE	22/08/19	105.13KB	Share
PYC	Company Re-branding		09/08/19	98.39KB	Share
PYC	Response to ASX Aware Query	PRICE SENSITIVE	07/08/19	738.05KB	Share
PYC	Phylogica's Technology is Effective in Human Cells	PRICE SENSITIVE	06/08/19	112.2KB	Share
PYC	Company Presentation - July 2019	PRICE SENSITIVE	24/07/19	1.38MB	Share
PYC	Operational Update and Appendix 4C	PRICE SENSITIVE	23/07/19	239.37KB	Share
PYC	Animal Models - 400% Outperformance of Gold Standard	PRICE SENSITIVE	23/07/19	93.57KB	Share
PYC	Break Through Animal Model Results	PRICE SENSITIVE	27/06/19	298.35KB	Share
PYC	March 2019 Quarterly Operational Update and App4C	PRICE SENSITIVE	29/04/19	130.46KB	Share
PYC	Change of Director's Interest Notice		24/04/19	108.42KB	Share
PYC	Scientific Advisory Board Appointment		22/03/19	65.95KB	Share
PYC	Collaboration Agreement - siRNA delivery	PRICE SENSITIVE	14/03/19	72.14KB	Share
PYC	Flagship Program - Successful Animal Models	PRICE SENSITIVE	12/03/19	90.4KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/19	629.87KB	Share
PYC	Director Resignation and App3Z		11/02/19	237.81KB	Share
PYC	First Competitive Read Out - Peptide Vaccine	PRICE SENSITIVE	08/02/19	95.97KB	Share
PYC	Dec 2018 Operational Update and App4C	PRICE SENSITIVE	31/01/19	171.31KB	Share
PYC	Conference Presentation - Keystone Symposia Vancouver		22/01/19	62.94KB	Share
PYC	CEO letter and Operational Update	PRICE SENSITIVE	17/01/19	385.08KB	Share
PYC	Executive Team Change		24/12/18	75.11KB	Share
PYC	Section 708A Notice		07/12/18	40.85KB	Share
PYC	In Vivo Success - peptide vaccine (Amended Graphics)	PRICE SENSITIVE	06/12/18	149.91KB	Share
PYC	In vivo success - peptide vaccine in Herpes Simplex Virus	PRICE SENSITIVE	06/12/18	207.42KB	Share
PYC	Notice of Change of Interest of Substantial Holder		04/12/18	137.29KB	Share
PYC	Director Interests Notices - Appendices 3X,Y and Z		04/12/18	323.95KB	Share
PYC	Appendix 3B		04/12/18	386.65KB	Share
PYC	Successful Delivery of CRIPR/Cas9 into Cells ex vivo	PRICE SENSITIVE	04/12/18	151.1KB	Share
PYC	Changes to the Board of Directors		30/11/18	77.27KB	Share
PYC	FNA Presentation	PRICE SENSITIVE	23/11/18	1.8MB	Share
PYC	Chairman's AGM Address and Results of Meeting		16/11/18	89.27KB	Share
PYC	AGM Company Presentation	PRICE SENSITIVE	16/11/18	1.39MB	Share
PYC	Sept 2018 Quarterly Operations Update and App4C	PRICE SENSITIVE	31/10/18	177.33KB	Share
PYC	Fourfold Delivery Improvement in a New Lead Candidate	PRICE SENSITIVE	29/10/18	70.4KB	Share
PYC	Notice of Annual General Meeting		15/10/18	151.6KB	Share
PYC	Corporate Governance Statement and Appendix 4G		15/10/18	249.78KB	Share
PYC	Annual Report to shareholders		15/10/18	6.95MB	Share
PYC	R&D Tax Incentive Refund	PRICE SENSITIVE	08/10/18	63.48KB	Share
PYC	Change of Director's Interest Notice		21/09/18	51.67KB	Share
PYC	Appendix 3B and Section 708A Notice		21/09/18	387.04KB	Share
PYC	Annual Financial Report		21/09/18	619.21KB	Share
PYC	Reinstatement to Official Quotation	PRICE SENSITIVE	12/09/18	403.81KB	Share
PYC	Phylogica Recapitalisation	PRICE SENSITIVE	12/09/18	64.61KB	Share
PYC	Update on Capital Raising	PRICE SENSITIVE	11/09/18	65.78KB	Share
PYC	Suspension from Official Quotation	PRICE SENSITIVE	11/09/18	484.03KB	Share
PYC	Trading Halt	PRICE SENSITIVE	07/09/18	274.88KB	Share
PYC	Preliminary Final Report	PRICE SENSITIVE	31/08/18	282.38KB	Share
PYC	Phylogicas platform described in Nature Scientific Report		23/08/18	82.89KB	Share
PYC	Delivering Cancer Treatment Inside Cells - Nature Oncogene		06/08/18	84.81KB	Share
PYC	June 2018 Quarterly Operational Update and App4C	PRICE SENSITIVE	31/07/18	224.74KB	Share
PYC	Achievement of Major Milestone - In vivo Cre Delivery	PRICE SENSITIVE	30/07/18	80.79KB	Share
PYC	Successful In-vivo Results Peptide Vaccine T-Cell Expansion	PRICE SENSITIVE	27/07/18	70.3KB	Share
PYC	Peer Reviewed Journal Publication		16/07/18	71.67KB	Share
PYC	Change in substantial holding		10/07/18	206.28KB	Share
PYC	CEO Update	PRICE SENSITIVE	09/07/18	114.19KB	Share
PYC	Chief Executive Officer Employment Terms		29/06/18	45.9KB	Share
PYC	Investor Presentation - May 2018		11/05/18	1.44MB	Share
PYC	Trading Policy		03/05/18	111.12KB	Share
PYC	Appendix 3B		03/05/18	341.99KB	Share
PYC	Final Director's Interest Notice		02/05/18	203.29KB	Share
PYC	March Quarter Investor Call Details		30/04/18	90.89KB	Share
PYC	March 2018 Operational Update and Cashflow	PRICE SENSITIVE	30/04/18	238.56KB	Share
PYC	Initial and Change of Director's Interest Notices		12/04/18	240.89KB	Share
PYC	Changes to Board and Management	PRICE SENSITIVE	11/04/18	35.65KB	Share
PYC	Notice of Change of Interest of Substantial Shareholder		11/04/18	999.93KB	Share
PYC	Notice of Change of Interest of Substantial Shareholder		11/04/18	1.1MB	Share
PYC	Trading Halt	PRICE SENSITIVE	09/04/18	141.58KB	Share
PYC	Cre Enzyme Delivery Provides Validation & Strategic Value	PRICE SENSITIVE	02/03/18	446.56KB	Share
PYC	Dec 2017 Half-year financial statements & Appendix 4D	PRICE SENSITIVE	28/02/18	511.86KB	Share
PYC	Dec Quarterly Update and Appendix 4C	PRICE SENSITIVE	31/01/18	602.57KB	Share
PYC	Phylogica Appoints New Scientific Advisory Board Member		12/01/18	346.69KB	Share
PYC	Federal R&D Tax Credit Received	PRICE SENSITIVE	11/01/18	76.64KB	Share
PYC	PYC Pivot to Platform - BioShowcase Presentation		09/01/18	13.33MB	Share
PYC	FPP Results Effective in Delivering Peptide Cancer Vaccine	PRICE SENSITIVE	08/01/18	109.79KB	Share
PYC	Appendix 3B and 3Y		05/01/18	283.95KB	Share
PYC	Appointment of Non-Executive Director and Appendix 3X		03/01/18	459.63KB	Share
PYC	Phylogica Strategic Update - Pivot to Platform	PRICE SENSITIVE	04/12/17	123.57KB	Share
PYC	Final Director's Interest Notice		01/12/17	260.38KB	Share
PYC	Appendix 3B and 3Y's		30/11/17	301.21KB	Share
PYC	Company Presentation - 2017 Annual General Meeting		27/11/17	5.61MB	Share
PYC	Chairman's Address - 2017 Annual General Meeting		27/11/17	75.04KB	Share
PYC	Results of Annual General Meeting		24/11/17	62.98KB	Share
PYC	Paul Watt Joins Phylogica Scientific Advisory Board		21/11/17	64.28KB	Share
PYC	Company Presentation- BIO Europe November 2017		06/11/17	15.61MB	Share

PYC Sept 2019 Quarterly Shareholder Update and Appendix 4C
30/10/19	PRICE SENSITIVE	192.66KB	Share
PYC Coprporate Governance Statement
21/10/19		128.14KB	Share
PYC Appendix 4G
18/10/19		168.97KB	Share
PYC Annual Report to shareholders
18/10/19		2.87MB	Share
PYC Notice of Annual General Meeting/Proxy Form
18/10/19		260.4KB	Share
PYC Investor Relations Presentation - October 2019
15/10/19		1.19MB	Share
PYC Presentation Oligonucleotide Therapeutics Society Meeting
14/10/19		115.98KB	Share
PYC Successful Major Milestone - Human Retina in a Dish Models
09/10/19	PRICE SENSITIVE	368.07KB	Share
PYC Strategic Partnership and Lead Program
01/10/19	PRICE SENSITIVE	204.29KB	Share
PYC Trading Halt
30/09/19	PRICE SENSITIVE	151.93KB	Share
PYC Successful Time-Course Studies in Animals
25/09/19	PRICE SENSITIVE	85.62KB	Share
PYC Full Year Statutory Accounts
17/09/19		862.71KB	Share
PYC Scientific Advisory Board Appointment
13/09/19		157.06KB	Share
PYC Investor Relations Presentation
04/09/19		1.44MB	Share
PYC Successful Competitive Drug Evaluation in Animals
03/09/19	PRICE SENSITIVE	326.49KB	Share
PYC Preliminary Final Report
30/08/19	PRICE SENSITIVE	300.77KB	Share
PYC Investor Call
23/08/19		94.49KB	Share
PYC Successful Time - Course Studies in Animals
22/08/19	PRICE SENSITIVE	105.13KB	Share
PYC Company Re-branding
09/08/19		98.39KB	Share
PYC Response to ASX Aware Query
07/08/19	PRICE SENSITIVE	738.05KB	Share
PYC Phylogica's Technology is Effective in Human Cells
06/08/19	PRICE SENSITIVE	112.2KB	Share
PYC Company Presentation - July 2019
24/07/19	PRICE SENSITIVE	1.38MB	Share
PYC Operational Update and Appendix 4C
23/07/19	PRICE SENSITIVE	239.37KB	Share
PYC Animal Models - 400% Outperformance of Gold Standard
23/07/19	PRICE SENSITIVE	93.57KB	Share
PYC Break Through Animal Model Results
27/06/19	PRICE SENSITIVE	298.35KB	Share
PYC March 2019 Quarterly Operational Update and App4C
29/04/19	PRICE SENSITIVE	130.46KB	Share
PYC Change of Director's Interest Notice
24/04/19		108.42KB	Share
PYC Scientific Advisory Board Appointment
22/03/19		65.95KB	Share
PYC Collaboration Agreement - siRNA delivery
14/03/19	PRICE SENSITIVE	72.14KB	Share
PYC Flagship Program - Successful Animal Models
12/03/19	PRICE SENSITIVE	90.4KB	Share
PYC Half Yearly Report and Accounts
28/02/19	PRICE SENSITIVE	629.87KB	Share
PYC Director Resignation and App3Z
11/02/19		237.81KB	Share
PYC First Competitive Read Out - Peptide Vaccine
08/02/19	PRICE SENSITIVE	95.97KB	Share
PYC Dec 2018 Operational Update and App4C
31/01/19	PRICE SENSITIVE	171.31KB	Share
PYC Conference Presentation - Keystone Symposia Vancouver
22/01/19		62.94KB	Share
PYC CEO letter and Operational Update
17/01/19	PRICE SENSITIVE	385.08KB	Share
PYC Executive Team Change
24/12/18		75.11KB	Share
PYC Section 708A Notice
07/12/18		40.85KB	Share
PYC In Vivo Success - peptide vaccine (Amended Graphics)
06/12/18	PRICE SENSITIVE	149.91KB	Share
PYC In vivo success - peptide vaccine in Herpes Simplex Virus
06/12/18	PRICE SENSITIVE	207.42KB	Share
PYC Notice of Change of Interest of Substantial Holder
04/12/18		137.29KB	Share
PYC Director Interests Notices - Appendices 3X,Y and Z
04/12/18		323.95KB	Share
PYC Appendix 3B
04/12/18		386.65KB	Share
PYC Successful Delivery of CRIPR/Cas9 into Cells ex vivo
04/12/18	PRICE SENSITIVE	151.1KB	Share
PYC Changes to the Board of Directors
30/11/18		77.27KB	Share
PYC FNA Presentation
23/11/18	PRICE SENSITIVE	1.8MB	Share
PYC Chairman's AGM Address and Results of Meeting
16/11/18		89.27KB	Share
PYC AGM Company Presentation
16/11/18	PRICE SENSITIVE	1.39MB	Share
PYC Sept 2018 Quarterly Operations Update and App4C
31/10/18	PRICE SENSITIVE	177.33KB	Share
PYC Fourfold Delivery Improvement in a New Lead Candidate
29/10/18	PRICE SENSITIVE	70.4KB	Share
PYC Notice of Annual General Meeting
15/10/18		151.6KB	Share
PYC Corporate Governance Statement and Appendix 4G
15/10/18		249.78KB	Share
PYC Annual Report to shareholders
15/10/18		6.95MB	Share
PYC R&D Tax Incentive Refund
08/10/18	PRICE SENSITIVE	63.48KB	Share
PYC Change of Director's Interest Notice
21/09/18		51.67KB	Share
PYC Appendix 3B and Section 708A Notice
21/09/18		387.04KB	Share
PYC Annual Financial Report
21/09/18		619.21KB	Share
PYC Reinstatement to Official Quotation
12/09/18	PRICE SENSITIVE	403.81KB	Share
PYC Phylogica Recapitalisation
12/09/18	PRICE SENSITIVE	64.61KB	Share
PYC Update on Capital Raising
11/09/18	PRICE SENSITIVE	65.78KB	Share
PYC Suspension from Official Quotation
11/09/18	PRICE SENSITIVE	484.03KB	Share
PYC Trading Halt
07/09/18	PRICE SENSITIVE	274.88KB	Share
PYC Preliminary Final Report
31/08/18	PRICE SENSITIVE	282.38KB	Share
PYC Phylogicas platform described in Nature Scientific Report
23/08/18		82.89KB	Share
PYC Delivering Cancer Treatment Inside Cells - Nature Oncogene
06/08/18		84.81KB	Share
PYC June 2018 Quarterly Operational Update and App4C
31/07/18	PRICE SENSITIVE	224.74KB	Share
PYC Achievement of Major Milestone - In vivo Cre Delivery
30/07/18	PRICE SENSITIVE	80.79KB	Share
PYC Successful In-vivo Results Peptide Vaccine T-Cell Expansion
27/07/18	PRICE SENSITIVE	70.3KB	Share
PYC Peer Reviewed Journal Publication
16/07/18		71.67KB	Share
PYC Change in substantial holding
10/07/18		206.28KB	Share
PYC CEO Update
09/07/18	PRICE SENSITIVE	114.19KB	Share
PYC Chief Executive Officer Employment Terms
29/06/18		45.9KB	Share
PYC Investor Presentation - May 2018
11/05/18		1.44MB	Share
PYC Trading Policy
03/05/18		111.12KB	Share
PYC Appendix 3B
03/05/18		341.99KB	Share
PYC Final Director's Interest Notice
02/05/18		203.29KB	Share
PYC March Quarter Investor Call Details
30/04/18		90.89KB	Share
PYC March 2018 Operational Update and Cashflow
30/04/18	PRICE SENSITIVE	238.56KB	Share
PYC Initial and Change of Director's Interest Notices
12/04/18		240.89KB	Share
PYC Changes to Board and Management
11/04/18	PRICE SENSITIVE	35.65KB	Share
PYC Notice of Change of Interest of Substantial Shareholder
11/04/18		999.93KB	Share
PYC Notice of Change of Interest of Substantial Shareholder
11/04/18		1.1MB	Share
PYC Trading Halt
09/04/18	PRICE SENSITIVE	141.58KB	Share
PYC Cre Enzyme Delivery Provides Validation & Strategic Value
02/03/18	PRICE SENSITIVE	446.56KB	Share
PYC Dec 2017 Half-year financial statements & Appendix 4D
28/02/18	PRICE SENSITIVE	511.86KB	Share
PYC Dec Quarterly Update and Appendix 4C
31/01/18	PRICE SENSITIVE	602.57KB	Share
PYC Phylogica Appoints New Scientific Advisory Board Member
12/01/18		346.69KB	Share
PYC Federal R&D Tax Credit Received
11/01/18	PRICE SENSITIVE	76.64KB	Share
PYC PYC Pivot to Platform - BioShowcase Presentation
09/01/18		13.33MB	Share
PYC FPP Results Effective in Delivering Peptide Cancer Vaccine
08/01/18	PRICE SENSITIVE	109.79KB	Share
PYC Appendix 3B and 3Y
05/01/18		283.95KB	Share
PYC Appointment of Non-Executive Director and Appendix 3X
03/01/18		459.63KB	Share
PYC Phylogica Strategic Update - Pivot to Platform
04/12/17	PRICE SENSITIVE	123.57KB	Share
PYC Final Director's Interest Notice
01/12/17		260.38KB	Share
PYC Appendix 3B and 3Y's
30/11/17		301.21KB	Share
PYC Company Presentation - 2017 Annual General Meeting
27/11/17		5.61MB	Share
PYC Chairman's Address - 2017 Annual General Meeting
27/11/17		75.04KB	Share
PYC Results of Annual General Meeting
24/11/17		62.98KB	Share
PYC Paul Watt Joins Phylogica Scientific Advisory Board
21/11/17		64.28KB	Share
PYC Company Presentation- BIO Europe November 2017
06/11/17		15.61MB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.19		Change 0.005(0.42%)		Mkt cap ! $691.1M

Open	High	Low	Value	Volume
$1.20	$1.21	$1.19	$410.5K	343.0K

Buyers (Bids)

No.	Vol.	Price($)
1	15611	$1.19

Sellers (Offers)

Price($)	Vol.	No.
$1.20	20000	1

View Market Depth

No.	Vol.	Price($)
1	15611	1.185
2	8874	1.180
4	77891	1.150
1	50000	1.140
1	889	1.125

Price($)	Vol.	No.
1.200	20000	1
1.205	2270	1
1.220	3582	2
1.240	15563	2
1.250	4333	2

Last trade - 16.10pm 13/06/2025 (20 minute delay)

PYC (ASX) Chart

PYC THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories